Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
Apply
Eganelisib with Venetoclax, Azacitidine
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step